Efficacy and Safety of Maralixibat (SHP625) in the Treatment of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC)
Condition: Cholestasis Interventions: Drug: Maralixibat; Drug: Placebo Sponsor: Shire Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cholestasis | Obstetric Cholestasis